| Autor: |
Marouen Mahjoub, Zohra Dridi, Nidhal Bouchahda, Fethi Betbout, Ibtihel Mechri, Mejdi Ben Massoud, Majed Hassine, Ghassen Chniti, Habib Gamra |
| Rok vydání: |
2015 |
| Předmět: |
|
| Zdroj: |
Archives of Cardiovascular Diseases Supplements. 7:50 |
| ISSN: |
1878-6480 |
| DOI: |
10.1016/s1878-6480(15)71630-7 |
| Popis: |
Background Percutaneous transvenous mitral balloon valvotomy (PTMV) optimal results are usually achieved when echocardiographic Wilkins score (WS) is ≤8. WS from 9 to 11 represent a gray zone in which only some patients have good results. Aim The aim of this study was to determine the early and long term results of this procedure in patients with WS 8 or less and at the gray WS zone. Methods Retrospective review of clinical records of patients with rheumatic MS submitted to PTMV from January 1990 to December 2010. Follow-up was obtained by clinical records when available. Procedure was considered unsuccessful when post-procedure MV area (MVA) was Results We analyzed data for 378 patients with a WS ≤11, 80.5% were women. Mean age at the time of repair was 33 years [10 to 76 years] and the mean follow up time was 74 months. Before the procedure, 33.9% had a WS in the gray zone. They were older (36 years vs. 31 years, p PTMV was safe in the two groups with same rates of success but a lower mitral surface gain in the gray zone group (0.88cm2 vs. 1.05cm2, p During follow up, patients in the gray zone had significantly lower event free survival (freedom from death, systemic embolism and restenosis) (58.6% vs. 69.2%, p Conclusion PTMV was a safe procedure in both WS groups. Optimal results patients with a WS≤8 zone. Patients with a WS 9-11 experienced worse outcomes during follow up. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect